Computational and in vitro analyses to identify the anticoagulant regions of Echicetin, a snake venom anticoagulant C-type lectin (snaclec): possibility to develop anticoagulant peptide therapeutics?

References

• Almeida, J., Resende, L., Watanabe, R. K., Carregari, V. C., Huancahuire-Vega, S., da S Caldeira, C. A., Coutinho-Neto, A., Soares, A. M., Vale, N., de C. Gomes, P. A., Marangoni, S., de A. Calderon, L., & Da Silva, S. L. (2017). Snake venom peptides and low mass proteins: Molecular tools and therapeutic agents. Current Medicinal Chemistry, 24(30), 3254–3282.
   PubMed Web of Science ®Google Scholar
• Arlinghaus, F. T., & Eble, J. A. (2012). C-type lectin-like proteins from snake venoms. Toxicon, 60(4), 512–519.
   PubMed Web of Science ®Google Scholar
• Bawaskar, H. S., Bawaskar, P. H., & Bawaskar, P. H. (2017). Snake bite in India: A neglected disease of poverty. The Lancet, 390(10106), 1947–1948.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56.
   Web of Science ®Google Scholar
• Bode, W. (2006). Structure and interaction modes of thrombin. Blood Cells, Molecules, and Diseases, 36(2), 122–130.
   PubMed Web of Science ®Google Scholar
• Brinkhous, K., Read, M., Fricke, W., & Wagner, R. (1983). Botrocetin (venom coagglutinin): Reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proceedings of the National Academy of Sciences of the United States of America, 80(5), 1463–1466.
   PubMed Web of Science ®Google Scholar
• Byoki, E. A., & Mirakabadi, A. Z. (2013). Partial Purification and characterization of anticoagulant factor from the snake (Echis carinatus) venom. Iranian Journal of Basic Medical Sciences, 16(11), 1139.
   PubMed Web of Science ®Google Scholar
• Casewell, N. R., Jackson, T. N., Laustsen, A. H., & Sunagar, K. (2020). Causes and consequences of snake venom variation. Trends in Pharmacological Sciences, 41(8), 570–581.
   PubMed Web of Science ®Google Scholar
• Chanda, A., & Mukherjee, A. K. (2020). Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: Opening new avenues in clinical research. Expert Review of Proteomics, 17(5), 411–423.
   PubMed Web of Science ®Google Scholar
• Chérifi, F., & Laraba-Djebari, F. (2021). Bioactive molecules derived from snake venoms with therapeutic potential for the treatment of thrombo-cardiovascular disorders associated with COVID-19. The Protein Journal, 40(6), 799–841.
   PubMed Web of Science ®Google Scholar
• Clemetson, K. J. (2010). Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors. Toxicon, 56(7), 1236–1246.
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519.
   PubMed Web of Science ®Google Scholar
• Das, N. C., Chakraborty, P., Bayry, J., & Mukherjee, S. (2022). In silico analyses on the comparative potential of therapeutic human monoclonal antibodies against newly emerged SARS-CoV-2 variants bearing mutant spike protein. Frontiers in Immunology, 12, 5576.
   Web of Science ®Google Scholar
• Das, N. C., Sen Gupta, P. S., Biswal, S., Patra, R., Rana, M. K., & Mukherjee, S. (2022). In-silico evidences on filarial cystatin as a putative ligand of human TLR4. Journal of Biomolecular Structure and Dynamics, 40(19), 8808–8824.
   PubMed Web of Science ®Google Scholar
• Del Gatto, A., Cobb, S. L., Zhang, J., & Zaccaro, L. (2021). Peptidomimetics: Synthetic tools for drug discovery and development. Frontiers in Chemistry, 9, 802120. https://doi.org/10.3389/fchem.2021.802120
   PubMed Web of Science ®Google Scholar
• Dimitrov, I., Bangov, I., Flower, D. R., & Doytchinova, I. (2014). AllerTOP v. 2—A server for in silico prediction of allergens. Journal of Molecular Modeling, 20, 1–6.
   Web of Science ®Google Scholar
• Dimitrov, I., Naneva, L., Doytchinova, I., & Bangov, I. (2014). AllergenFP: Allergenicity prediction by descriptor fingerprints. Bioinformatics, 30(6), 846–851.
   PubMed Web of Science ®Google Scholar
• Doley, R., King, G. F., & Mukherjee, A. K. (2004). Differential hydrolysis of erythrocyte and mitochondrial membrane phospholipids by two phospholipase A2 isoenzymes (NK-PLA2-I and NK-PLA2-II) from the venom of the Indian monocled cobra Naja kaouthia. Archives of Biochemistry and Biophysics, 425(1), 1–13.
   PubMed Web of Science ®Google Scholar
• Doley, R., & Mukherjee, A. K. (2003). Purification and characterization of an anticoagulant phospholipase A2 from Indian monocled cobra (Naja kaouthia) venom. Toxicon, 41(1), 81–91.
   PubMed Web of Science ®Google Scholar
• Dutta, S., Chanda, A., Kalita, B., Islam, T., Patra, A., & Mukherjee, A. K. (2017). Proteomic analysis to unravel the complex venom proteome of eastern India Naja naja: Correlation of venom composition with its biochemical and pharmacological properties. Journal of Proteomics, 156, 29–39. https://doi.org/10.1016/j.jprot.2016.12.018
   PubMed Web of Science ®Google Scholar
• Dutta, S., Gogoi, D., & Mukherjee, A. K. (2015). Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: Inhibition of anticoagulant activity by low molecular weight heparin. Biochimie, 110, 93–106. https://doi.org/10.1016/j.biochi.2014.12.020
   PubMed Web of Science ®Google Scholar
• Dutta, S., Sinha, A., Dasgupta, S., & Mukherjee, A. K. (2019). Binding of a Naja naja venom acidic phospholipase A2 cognate complex to membrane-bound vimentin of rat L6 cells: Implications in cobra venom-induced cytotoxicity. Biochimica et Biophysica Acta. Biomembranes, 1861(5), 958–977. https://doi.org/10.1016/j.bbamem.2019.02.002
   PubMed Web of Science ®Google Scholar
• Faisal, T., Tan, K. Y., Sim, S. M., Quraishi, N., Tan, N. H., & Tan, C. H. (2018). Proteomics, functional characterization and antivenom neutralization of the venom of Pakistani Russell’s viper (Daboia russelii) from the wild. Journal of Proteomics, 183, 1–13. https://doi.org/10.1016/j.jprot.2018.05.003
   PubMed Web of Science ®Google Scholar
• Faure, G., Gowda, V. T., & Maroun, R. C. (2007). Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics. BMC Structural Biology, 7(1), 1–19.
   PubMedGoogle Scholar
• Faure, G., & Saul, F. (2011). Structural and functional characterization of anticoagulant, FXa-binding Viperidae snake venom phospholipases A2. Acta Chimica Slovenica, 58(4), 671–677
   PubMed Web of Science ®Google Scholar
• Fosgerau, K., & Hoffmann, T. (2015). Peptide therapeutics: Current status and future directions. Drug Discovery Today, 20(1), 122–128.
   PubMed Web of Science ®Google Scholar
• Fox, J. W., & Serrano, S. M. (2008). Exploring snake venom proteomes: Multifaceted analyses for complex toxin mixtures. Proteomics, 8(4), 909–920.
   PubMed Web of Science ®Google Scholar
• Frangieh, J., Rima, M., Fajloun, Z., Henrion, D., Sabatier, J.-M., Legros, C., & Mattei, C. (2021). Snake venom components: Tools and cures to target cardiovascular diseases. Molecules, 26(8), 2223.
   PubMed Web of Science ®Google Scholar
• Gorai, S., Das, N. C., Gupta, P. S. S., Panda, S. K., Rana, M. K., & Mukherjee, S. (2022). Designing efficient multi-epitope peptide-based vaccine by targeting the antioxidant thioredoxin of bancroftian filarial parasite. Infection, Genetics and Evolution, 98, 105237.
   PubMed Web of Science ®Google Scholar
• Gupta, P. S. S., Bhat, H. R., Biswal, S., & Rana, M. K. (2020). Computer-aided discovery of bis-indole derivatives as multi-target drugs against cancer and bacterial infections: DFT, docking, virtual screening, and molecular dynamics studies. Journal of Molecular Liquids, 320, 114375.
   Web of Science ®Google Scholar
• Herr, A. B. (2017). Charming the snake: Venom-derived peptides show surprising efficacy as glycoprotein VI-targeting antithrombotic agents. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(7), 1266–1268.
   PubMed Web of Science ®Google Scholar
• Kalita, B., Mackessy, S. P., & Mukherjee, A. K. (2018). Proteomic analysis reveals geographic variation in venom composition of Russell’s viper in the Indian subcontinent: Implications for clinical manifestations post-envenomation and antivenom treatment. Expert Review of Proteomics, 15(10), 837–849.
   PubMed Web of Science ®Google Scholar
• Kalita, B., & Mukherjee, A. K. (2019). Recent advances in snake venom proteomics research in India: A new horizon to decipher the geographical variation in venom proteome composition and exploration of candidate drug prototypes. Journal of Proteins and Proteomics, 10(2), 149–164.
   Google Scholar
• Kalita, B., Patra, A., & Mukherjee, A. K. (2017). Unraveling the proteome composition and immuno-profiling of western India Russell’s viper venom for in-depth understanding of its pharmacological properties, clinical manifestations, and effective antivenom treatment. Journal of Proteome Research, 16(2), 583–598.
   PubMed Web of Science ®Google Scholar
• Kalita, B., Saviola, A. J., Samuel, S. P., & Mukherjee, A. K. (2021). State-of-the-art review—A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? International Journal of Biological Macromolecules, 192, 1040–1057. https://doi.org/10.1016/j.ijbiomac.2021.10.015
   PubMed Web of Science ®Google Scholar
• Kalita, B., Singh, S., Patra, A., & Mukherjee, A. K. (2018). Quantitative proteomic analysis and antivenom study revealing that neurotoxic phospholipase A2 enzymes, the major toxin class of Russell’s viper venom from southern India, shows the least immuno-recognition and neutralization by commercial polyvalent antivenom. International Journal of Biological Macromolecules, 118, 375–385.
   PubMed Web of Science ®Google Scholar
• Kerns, R. T., Kini, R. M., Stefansson, S., & Evans, H. J. (1999). Targeting of venom phospholipases: The strongly anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex. Archives of Biochemistry and Biophysics, 369(1), 107–113.
   PubMed Web of Science ®Google Scholar
• King, G. (2013). Venoms to drugs: Translating venom peptides into therapeutics. Australian Biochemist, 44(3), 13–15.
   Google Scholar
• Koh, D., Armugam, A., & Jeyaseelan, K. (2006). Snake venom components and their applications in biomedicine. Cellular and Molecular Life Sciences, 63(24), 3030–3041.
   PubMed Web of Science ®Google Scholar
• Koh, C. Y., & Kini, R. M. (2012). From snake venom toxins to therapeutics—Cardiovascular examples. Toxicon, 59(4), 497–506.
   PubMed Web of Science ®Google Scholar
• Kumar, J., Basavarajappa, B. S., Arancio, O., Aranha, I., Gangadhara, N., Yajurvedi, H., & Gowda, T. V. (2008). Isolation and characterization of “Reprotoxin”, a novel protein complex from Daboia russelii snake venom. Biochimie, 90(10), 1545–1559.
   PubMed Web of Science ®Google Scholar
• Ladner, R. C., Sato, A. K., Gorzelany, J., & de Souza, M. (2004). Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discovery Today, 9(12), 525–529.
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291.
   Web of Science ®Google Scholar
• Lu, Q., Navdaev, A., Clemetson, J. M., & Clemetson, K. J. (2005). Snake venom C-type lectins interacting with platelet receptors. Structure–function relationships and effects on haemostasis. Toxicon, 45(8), 1089–1098.
   PubMed Web of Science ®Google Scholar
• McCleary, R. J., & Kini, R. M. (2013). Snake bites and hemostasis/thrombosis. Thrombosis Research, 132(6), 642–646.
   PubMed Web of Science ®Google Scholar
• McGregor, D. P. (2008). Discovering and improving novel peptide therapeutics. Current Opinion in Pharmacology, 8(5), 616–619.
   PubMed Web of Science ®Google Scholar
• Mizuno, H., Fujimoto, Z., Atoda, H., & Morita, T. (2001). Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proceedings of the National Academy of Sciences of the United States of America, 98(13), 7230–7234.
   PubMed Web of Science ®Google Scholar
• Mizuno, H., Fujimoto, Z., Koizumi, M., Kano, H., Atoda, H., & Morita, T. (1999). Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 Å: Implication of central loop swapping based on deletion in the linker region. Journal of Molecular Biology, 289(1), 103–112.
   PubMed Web of Science ®Google Scholar
• Mukherjee, A. K. (2010). Non-covalent interaction of phospholipase A2 (PLA2) and kaouthiotoxin (KTX) from venom of Naja kaouthia exhibits marked synergism to potentiate their cytotoxicity on target cells. Journal of Venom Research, 1, 37–42.
   PubMedGoogle Scholar
• Mukherjee, A. K. (2021a). Indian Russell’s viper (Daboia russelii). In The ‘Big Four’ snakes of India (pp. 105–134). Springer.
   Google Scholar
• Mukherjee, A. K. (2021b). Indian saw-scaled viper (Echis carinatus carinatus). In The ‘Big Four’ snakes of India (pp. 135–144). Springer.
   Google Scholar
• Mukherjee, A. K., Dutta, S., Kalita, B., Jha, D. K., Deb, P., & Mackessy, S. P. (2016). Structural and functional characterization of complex formation between two Kunitz-type serine protease inhibitors from Russell’s viper venom. Biochimie, 128, 138–147.
   PubMed Web of Science ®Google Scholar
• Mukherjee, A. K., Dutta, S., & Mackessy, S. P. (2014). A new C-type lectin (RVsnaclec) purified from venom of Daboia russelii russelii shows anticoagulant activity via inhibition of FXa and concentration-dependent differential response to platelets in a Ca2+-independent manner. Thrombosis Research, 134(5), 1150–1156.
   PubMed Web of Science ®Google Scholar
• Mukherjee, A. K., Kalita, B., Dutta, S., Patra, A., Maiti, C. R., & Punde, D. (2021). Snake envenomation: Therapy and challenges in India. In Stephen P. Mackessy (Ed.), Handbook of venoms and toxins of reptiles (pp. 581–592). CRC Press.
   Google Scholar
• Navdaev, A., Dörmann, D., Clemetson, J. M., & Clemetson, K. J. (2001). Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMκ responsible for platelet agglutination in plasma and inducing signal transduction. Blood, 97(8), 2333–2341.
   PubMed Web of Science ®Google Scholar
• Osipov, A. V., Filkin, S. Y., Makarova, Y. V., Tsetlin, V. I., & Utkin, Y. N. (2010). A new type of thrombin inhibitor, noncytotoxic phospholipase A2, from the Naja haje cobra venom. Toxicon, 55(2–3), 186–194.
   PubMed Web of Science ®Google Scholar
• Patra, A., Banerjee, D., Dasgupta, S., & Mukherjee, A. K. (2021). The in vitro laboratory tests and mass spectrometry-assisted quality assessment of commercial polyvalent antivenom raised against the ‘Big Four’ venomous snakes of India. Toxicon, 192, 15–31. https://doi.org/10.1016/j.toxicon.2020.12.015
   PubMed Web of Science ®Google Scholar
• Patra, A., Kalita, B., Chanda, A., & Mukherjee, A. K. (2017). Proteomics and antivenomics of Echis carinatus carinatus venom: Correlation with pharmacological properties and pathophysiology of envenomation. Scientific Reports, 7(1), 1–17.
   PubMedGoogle Scholar
• Peng, M., Emig, F. A., Mao, A., Lu, W., Kirby, E. P., Niewiarowski, S., & Kowalska, M. A. (1995). Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb. Thrombosis and Haemostasis, 74(3), 954–957.
   PubMed Web of Science ®Google Scholar
• Peng, M., Holt, J. C., & Niewiarowski, S. (1994). Isolation, characterization and amino acid sequence of echicetin β subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochemical and Biophysical Research Communications, 205(1), 68–72.
   PubMed Web of Science ®Google Scholar
• Peng, M., Lu, W., Beviglia, L., Niewiarowski, S., & Kirby, E. P. (1993). Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood, 81(9), 2321–2328.
   PubMed Web of Science ®Google Scholar
• Pérez-Peinado, C., Defaus, S., & Andreu, D. J. T. (2020). Hitchhiking with Nature: Snake venom peptides to fight cancer and superbugs. Toxins, 12(4), 255.
   PubMed Web of Science ®Google Scholar
• Prijatelj, P., Charnay, M., Ivanovski, G., Jenko, Z., Pungerčar, J., Križaj, I., & Faure, G. (2006). The C-terminal and β-wing regions of ammodytoxin A, a neurotoxic phospholipase A2 from Vipera ammodytes ammodytes, are critical for binding to factor Xa and for anticoagulant effect. Biochimie, 88(1), 69–76.
   PubMed Web of Science ®Google Scholar
• Sato, A. K., Viswanathan, M., Kent, R. B., & Wood, C. R. (2006). Therapeutic peptides: Technological advances driving peptides into development. Current Opinion in Biotechnology, 17(6), 638–642.
   PubMed Web of Science ®Google Scholar
• Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008). Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 133(6), 257S–2298.
   PubMed Web of Science ®Google Scholar
• Senji Laxme, R., Attarde, S., Khochare, S., Suranse, V., Martin, G., Casewell, N. R., Whitaker, R., & Sunagar, K. (2021). Biogeographical venom variation in the Indian spectacled cobra (Naja naja) underscores the pressing need for pan-India efficacious snakebite therapy. PLoS Neglected Tropical Diseases, 15(2), e0009150.
   PubMed Web of Science ®Google Scholar
• Senji Laxme, R., Khochare, S., de Souza, H. F., Ahuja, B., Suranse, V., Martin, G., Whitaker, R., & Sunagar, K. (2019). Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies. PLoS Neglected Tropical Diseases, 13(12), e0007899.
   PubMed Web of Science ®Google Scholar
• Sharma, M., Iyer, J. K., Shih, N., Majumder, M., Mattaparthi, V. S. K., Mukhopadhyay, R., & Doley, R. (2016). Daboxin p, a major phospholipase A2 enzyme from the Indian Daboia russelii russelii venom targets factor X and factor Xa for its anticoagulant activity. PLoS One, 11(4), e0153770.
   PubMed Web of Science ®Google Scholar
• Srikumar, P., Rohini, K., & Rajesh, P. K. (2014). Molecular dynamics simulations and principal component analysis on human laforin mutation W32G and W32G/K87A. The Protein Journal, 33(3), 289–295. https://doi.org/10.1007/s10930-014-9561-2
   PubMed Web of Science ®Google Scholar
• Thakur, R., Chattopadhyay, P., & Mukherjee, A. K. (2015). Biochemical and pharmacological characterization of a toxic fraction and its cytotoxin-like component isolated from Russell’s viper (Daboia russelii russelii) venom. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 168, 55–65. https://doi.org/10.1016/j.cbpc.2014.12.001
   PubMed Web of Science ®Google Scholar
• Warrell, D. A., Gutiérrez, J. M., Calvete, J. J., & Williams, D. (2013). New approaches and technologies of venomics to meet the challenge of human envenoming by snakebites in India. Indian Journal of Medical Research, 138(1), 38–59.
   PubMedGoogle Scholar
• Zerbe, B. S., Hall, D. R., Vajda, S., Whitty, A., & Kozakov, D. (2012). Relationship between hot spot residues and ligand binding hot spots in protein–protein interfaces. Journal of Chemical Information and Modeling, 52(8), 2236–2244.
   PubMed Web of Science ®Google Scholar